Skip to content

Active ingredient

Eszopiclone

93 finished FDA listings contain Eszopiclone as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
ESZOPICLONE
Dosage forms
Tablet, Coated, Tablet, Film Coated
Routes
Oral, Oropharyngeal
Manufacturers / labelers
28
Strengths listed
1 mg/1 · 2 mg/1 · 3 mg/1
Brand names in FDA listings
Lunesta

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 461016

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021476WAYLIS THERAP2004-12-153
ANDA 091169TEVA2011-05-234
ANDA 091124LUPIN LTD2011-09-137
ANDA 091151MYLAN PHARMS INC2013-03-266
ANDA 091103SUN PHARM2013-04-033
ANDA 091166GLENMARK PHARMS LTD2014-04-1516
ANDA 091024DR REDDYS2014-04-155
ANDA 091113ORBION PHARMS2014-06-103
ANDA 202929MACLEODS PHARMS2015-01-3025
ANDA 208451AUROBINDO PHARMA2016-09-1516
ANDA 205504HETERO LABS LTD V2024-01-045

Official labeling on DailyMed

Showing the 12 most recent of 62 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.